|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase II Trial of Erlotinib and Capecitabine for Patients with Previously Untreated Metastatic Colorectal Cancer显示文摘 | Peter Kozuch Steve Malamud Carrie Wasserman Peter Homel Takhir Mirzoyev Michael Grossbard | 2009 | Clinical Colorectal Cancer2009，，1： | 2 |
| 2 | Phase Ⅱ study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma显示文摘 | VOSE J M LINK B K GROSSBARD M L | 2001 | J Clin Oncol2001，19，2： | 1 |
| 3 | Phase Ⅱ study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin' s lymphoma 显示文摘 | Vose JM Link BK Grossbard ML | 2001 | J Clin Oncol2001，19，2： | 1 |
| 4 | Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers 显示文摘 | Petersen BE Grossbard B Hatch H | 2003 | Hepatology2003，37，3： | 1 |
| 5 | Primary sys-temic therapy of breast cancer显示文摘 | Sachelarie I Grossbard ML Chadha M el a1 | 2006 | Oncologist2006，，6： | 1 |
| 6 | Metastatic pancreatic cancer: emerging strategies in chemotherapy and palliative care 显示文摘 | el-Kamar FG Grossbard ML Kozuch PS | 2003 | Oncologist2003，8，1： | 1 |
| 7 | An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment 显示文摘 | MELTZER E O BERKOWITZ R B GROSSBARD E B | 2005 | J Allergy Clin Immun2005，115，4： | 1 |
| 8 | Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers显示文摘 | PETERSEN B E GROSSBARD B HATCH H | 2003 | Hepatology2003，37，： | 1 |
| 9 | Mouse A6 -positive hepatie oval cells also express several hematopoietic stem cell markers 显示文摘 | PETERSEN B E GROSSBARD B HATCH H | 2003 | Hepatology2003，37，3： | 1 |
| 10 | Metastatic pancreatic cancer: emerging strategies in chemotherapy and palliative care显示文摘 | el Kamar FG Grossbard ML Kozuch PS | 2003 | Oncologist2003，8，1： | 1 |
| 11 | Primary Systemic Therapy of Breast Cancer 显示文摘 | I Sachelarie ML Grossbard M Chadha | 2006 | Oncologist2006，11，6： | 1 |
| 12 | A phase Ⅰ study of gemcitabine and docetaxel in patients with metastatic solid tumors显示文摘 | Ryan DP Lynch TJ Grossbard ML | 2000 | Cancer2000，88，： | 1 |
| 13 | Long term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated,aggressive non Hodgk in lvmphoma显示文摘 | Vose JM Link BK Grossbard MI | 2005 | Leuk Lymphoma2005，46，11： | 1 |
| 14 | Phase II study of ritux-imab in combination with CHOP chemotherapy in patients with pre-viously untreated,aggressive non Hodgkin lymphoma(NHL)显示文摘 | Vose JM Link BK Grossbard ML | 2001 | J Clin Oncol2001，19，： | 1 |
| 15 | Gallbladder and biliary tract carcinoma:A comprehensive update,Part 1显示文摘 | Rajagopalan V Daines W P Grossbard M L | 2004 | Oncology (Huntingt)2004，18，7： | 1 |
| 16 | Irinotecan com- bined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancer 显示文摘 | Kozuch P Grossbard ML Barzdins A | 2001 | On- cologist2001，6，6： | 1 |
| 17 | An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment显示文摘 | Meltzer E O Berkowitz R B Grossbard E B | 2005 | J Allergy Clin Immunol2005，115，： | 1 |
| 18 | Gallbladder and biliary tract carcinoma:A comprehensive update,Part 2显示文摘 | Daines W P Rajagopalan V Grossbard M L | 2004 | Oncology (Huntingt)2004，18，8： | 1 |
| 19 | Primary systemic therapy of breast cancer 显示文摘 | Sachelarie I Grossbard ML Chadha M | 2006 | Oncologist2006，11，6： | 1 |
| 20 | Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated,aggressive non-Hodgkin's lymphoma显示文摘 | Vose JM Link BK Grossbard ML | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员